We are live on
!
Find out more
PCM
Pathway Capital Management Portfolio holdings
AUM
$4.3M
1-Year Est. Return
62.8%
This Fund
S&P 500
This Quarter
Est. Return
+13.87%
1 Year Est. Return
+62.8%
3 Year Est. Return
+496.35%
5 Year Est. Return
+305.57%
10 Year Est. Return
–
AUM
$20.3M
AUM Growth
-$71M
(-78%)
Cap. Flow
-$72.2M
Cap. Flow
% of AUM
-355.04%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
14
New
4
Increased
2
Reduced
–
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hims & Hers Health
HIMS
|
+$6.11M |
| 2 |
ACLX
Arcellx
ACLX
|
+$3.68M |
| 3 |
CRISPR Therapeutics
CRSP
|
+$2.87M |
| 4 |
GoodRx Holdings
GDRX
|
+$1.77M |
| 5 |
Pinduoduo
PDD
|
+$852K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rubrik
RBRK
|
+$57.6M |
| 2 |
Toast
TOST
|
+$10.9M |
| 3 |
TTAN
ServiceTitan Inc
TTAN
|
+$6.86M |
| 4 |
Braze
BRZE
|
+$4.81M |
| 5 |
Sprinklr
CXM
|
+$4.62M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 90.68% |
| 2 | Consumer Discretionary | 4.68% |
| 3 | Financials | 4.64% |
| 4 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Hims & Hers Health
HIMS
$7.69B
| $6.77M | 33.26% |
+119,279
| New | +$6.11M |
|
|
ACLX
2
DELISTED
Arcellx
ACLX
| $4.19M | 20.6% |
+51,051
| New | +$3.68M |
|
|
3
GoodRx Holdings
GDRX
$1.08B
| $4.17M | 20.51% |
986,158
+402,721
| +69% | +$1.77M |
|
|
4
CRISPR Therapeutics
CRSP
$4.69B
| $3.24M | 15.95% |
+50,049
| New | +$2.87M |
|
|
5
Pinduoduo
PDD
$123B
| $951K | 4.68% |
+7,197
| New | +$852K |
|
6
Nu Holdings
NU
$68B
| $945K | 4.64% |
59,010
+22,746
| +63% | +$317K |
|
|
NEUE
7
DELISTED
NeueHealth
NEUE
| $74.7K | 0.37% |
11,201
| – | – |
|
8
Airbnb
ABNB
$86.3B
| – | – |
-2,266
| Closed | -$300K |
|
9
Amplitude
AMPL
$1.3B
| – | – |
-216,386
| Closed | -$2.68M |
|
|
10
Braze
BRZE
$3.01B
| – | – |
-171,289
| Closed | -$4.81M |
|
|
11
Sprinklr
CXM
$1.41B
| – | – |
-546,223
| Closed | -$4.62M |
|
|
12
Toast
TOST
$17.8B
| – | – |
-246,582
| Closed | -$10.9M |
|
|
13
Rubrik
RBRK
$16.3B
| – | – |
-643,199
| Closed | -$57.6M |
|
|
TTAN
14
ServiceTitan Inc
TTAN
$7.7B
| – | – |
-64,019
| Closed | -$6.86M |
|
Similar funds
CC
RA
ABA
UOMF
EAMS
KAM
FWA
RCP
Pathway Capital Management's Q3 2025 Portfolio in Review
As of Q3 2025, Pathway Capital Management held 14 positions worth $20.3M, down 78% from $91.3M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Pathway Capital Management withdrew a net $72.2M in Q3 2025, closing 7 positions. Its most notable exit was Rubrik, an estimated $57.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 91% of assets, up from 3.3% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Pathway Capital Management opened a new position in Hims & Hers Health worth $6.77M.
- Pathway Capital Management's largest Q3 2025 buy was Hims & Hers Health: 119,279 shares worth $6.77M.
- Pathway Capital Management added most to GoodRx Holdings in Q3 2025, an estimated $1.77M increase.
- Pathway Capital Management fully exited Rubrik in Q3 2025, selling an estimated $57.6M.
- Pathway Capital Management's ten largest holdings make up 100% of its $20.3M portfolio in Q3 2025.
- Pathway Capital Management opened 4 new positions and closed 7 in Q3 2025.
- Pathway Capital Management's portfolio value fell 78% quarter-over-quarter to $20.3M.
Based on Pathway Capital Management's 13F filing for Q3 2025, filed 4 Nov 2025.